Drug makers may profit from disease in global warming scourge

on

A report by PricewaterhouseCoopers LLP forecast that higher temperatures could lead to a doubling of the world pharmaceutical market in 13 years , with sales of medicines increasing to $1.3 trillion US from about $600 billion last year – provided drug makers find innovative treatments.

The New York-based accounting and consulting company, citing the Intergovernmental Panel on Climate Change, said the average temperature is projected to increase by 0.4 degrees Celsius during the next two decades and the increase could be greater if greenhouse-gas emissions increase.

Climate change may already be playing a role in reports of malaria in countries such as Turkey and Georgia where it was eradicated, the report said.

Related Posts

on
The agency is loosening methane rules while keeping its authority to regulate them. Critics say the stance leaves federal climate law in limbo, inviting a bigger rollback later.
on
Lord Agnew and Paul Marshall, who also owns The Spectator, are shareholders in Equinor and Shell.
on
A Q&A with Astra Taylor, co-author with Naomi Klein of ‘End Times Fascism and the Fight for the Living World.’
Analysis
on
Companies that have signed onto the voluntary rules might be violating them in Canada and the U.S.